Advanced Biomed Inc. Common Stock Financial Flexibility Index
Advanced Biomed Inc. Common Stock financial flexibility index. Advanced Biomed Inc. Common Stock (ADVB) has a Financial Flexibility Index of 0.00x as of March 2026. Free cash flow of $-6.86K (operating CF $-6.89K minus capex $34.59) represents 0% of total liabilities ($1.44 Million). Explore Advanced Biomed Inc. Common Stock capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Advanced Biomed Inc. Common Stock (2021–2025)
Financial flexibility index of Advanced Biomed Inc. Common Stock from 2021 to 2025. Historical Financial Flexibility Index trend for Advanced Biomed Inc. Common Stock across 5 annual periods. Check ADVB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Advanced Biomed Inc. Common Stock Financial Flexibility Index by Year (2021–2025)
Advanced Biomed Inc. Common Stock financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for Advanced Biomed Inc. Common Stock. For the full cash flow conversion analysis, see cash efficiency ratio of Advanced Biomed Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.06x | $-180.48K | $-181.46K | $3.03 Million | ▲ +91.9% |
| 2024 | -0.73x | $-2.05 Million | $-2.13 Million | $2.80 Million | ▲ +12.1% |
| 2023 | -0.84x | $-2.75 Million | $-2.96 Million | $3.29 Million | ▼ -571.5% |
| 2022 | 0.18x | $570.68K | $-741.45K | $3.22 Million | ▲ +101.2% |
| 2021 | -14.89x | $-448.53K | $-473.98K | $30.13K | — |